Pigmentation comes in many forms: sun spots, freckles, melasma, post-inflammatory marks, and deeper dermal conditions such as Hori’s nevus. Each requires a different approach.
At DermAlly, we provide tailored solutions for pigmentation removal in Singapore. Our experienced dermatologists assess each patient’s skin condition, skin pigmentation type, and medical history to develop a comprehensive treatment approach that may include laser treatment, prescription topicals, oral medications, and long-term maintenance care.
Pigmentation treatment at DermAlly is performed under the supervision of MOH-accredited consultant dermatologists across two locations: Camden Medical Centre (Orchard) and Katong i12 (East Coast). Treatment plans are calibrated for Asian skin (Fitzpatrick III–V), with PIH-aware protocols at every step.
Our dermatology team includes Dr Coni Liu, Dr Heng Jun Khee, and Dr Cheng Hui Mei, MOH-accredited consultant dermatologists with backgrounds spanning medical dermatology, pigmentary disorders, dermatologic laser treatment, skin surgery, and aesthetic dermatology.
Book A Consultation to learn more about our pigmentation removal treatments in Singapore.
Pigmentation refers to the colouration of the skin, hair, and eyes. It is determined by the amount and type of melanin, which is the primary pigment in the skin produced by cells called melanocytes. Hyperpigmentation is a common condition that makes some areas of the skin appear darker than others.
Hyperpigmentation is one of the most common skin concerns seen in Singapore. Year-round ultraviolet (UV) exposure, heat, and humidity all contribute to pigment activation, especially in Asian skin types with higher baseline melanin levels.
Skin of colour, including Fitzpatrick III–V skin types commonly seen in Singapore, is also more prone to post-inflammatory hyperpigmentation (PIH). Even relatively minor inflammation from acne, eczema, insect bites, or aggressive skincare can trigger lingering dark marks. Research also shows that Asian skin has a higher risk of rebound pigmentation when treatments are not appropriately selected.
Many people do not have just one type of pigmentation. Conditions such as melasma, PIH, freckles, and sun spots often overlap, which is why diagnosis matters before pigmentation treatment begins.
Skin pigmentation develops due to various factors, each contributing to the overproduction of melanin.
Individuals with a family history of pigmentation disorders may be genetically predisposed to develop similar conditions due to inherited traits that affect how their skin produces and distributes melanin.
Hormonal fluctuations, especially during pregnancy or as a result of hormonal therapies like birth control or hormone replacement therapy, can affect the skin, often leading to pigmentation changes. This is largely due to how hormones interact with melanocytes, the cells responsible for creating melanin.
Adrenal gland disorders like Addison’s disease can affect melanin production, changing skin pigmentation. The adrenal glands above the kidneys are crucial for regulating several hormones, including cortisol and aldosterone, which are vital for managing stress, metabolism, and immune response.
When the skin is exposed to harsh UV rays, it increases melanin production as a natural defence mechanism. Melanin absorbs UV radiation to protect the deeper layers of skin from damage.
Trauma to the skin, including cuts, burns, acne, or even cosmetic procedures, can often result in post-inflammatory hyperpigmentation. This condition occurs when the skin’s natural healing process following an injury triggers an overproduction of melanin in response to the inflammation. The result is the development of darkened areas or spots where the injury or inflammation occurred.
Certain medications, including some antibiotics, hormonal treatments, and other prescription drugs, can cause pigmentation changes as an unintended side effect. These medications can interfere with the regular functioning of melanocytes, leading to either darkening of the skin or, less commonly, lightening of the skin.
Drug-induced pigmentation is generally benign but can be cosmetically concerning for affected individuals.
Pigmentation is not diagnosed by colour alone. Dermatologists also assess where the pigment sits within the skin, what triggered it, and how the condition behaves over time. This matters because treatment response differs significantly between superficial and deeper pigmentation.
Some pigmentation sits closer to the surface and responds to topical treatment and laser. Other forms sit deeper within the skin and require longer-term, specialist-led treatment plans. In many patients, more than one type is present simultaneously.
Epidermal pigmentation sits within the epidermis, which is the top layer of the skin. It usually appears brown and generally responds well to topical and laser treatments, as well as consistent sun protection.
Dermal pigmentation sits deeper within the dermis. Because of how light scatters at this depth, these conditions often appear blue-grey, ash-brown, or slate-coloured rather than purely brown.
Dermal pigmentation usually responds more slowly to topical treatment alone and often requires laser-based treatment under specialist supervision.
Mixed pigmentation involves both epidermal and dermal pigment. These conditions are often more persistent and usually require a combination of treatment approaches.
Melasma typically presents as symmetrical brown or grey-brown patches on the cheeks, forehead, upper lip, jawline, or nose bridge. It is influenced by multiple factors, including hormones, pregnancy, contraceptive use, genetics, ultraviolet exposure, and heat.
Unlike isolated sun spots or freckles, melasma is a chronic and recurrent condition. It is managed long-term rather than permanently cured with a single laser session.
Treatment often involves a combination of topical depigmenting agents, prescription oral therapies, low-fluence laser treatment, and strict ongoing sun protection. In some patients, aggressive laser treatment may worsen inflammation and trigger rebound pigmentation, underscoring the importance of dermatologist-led treatment planning.
Post-inflammatory pigmentation develops after skin inflammation or trauma. Common triggers include acne, eczema, contact dermatitis, insect bites, burns, and overly aggressive cosmetic procedures.
These pigment changes are especially common in Asian skin types, where melanocytes are more reactive after inflammation.
PIE is treated differently from brown pigmentation. Yellow lasers are typically used to target vascular redness, whereas pigment-focused lasers, such as pico lasers, target melanin rather than blood vessels.
Many patients have more than one type of pigmentation at once. A dermatologist’s diagnosis is what sets them apart and determines whether laser, topicals, oral medication, or a combination is the right starting point.
Many conditions overlap, and treating the wrong one can worsen rather than improve the skin.
Pigmentation treatment starts with diagnosis, not laser selection. Different pigmentation conditions can look similar on the surface while behaving very differently underneath the skin. This is one reason why some treatments improve pigmentation, while others trigger rebound darkening or uneven results.
At DermAlly, diagnosis involves evaluating the type of pigmentation, how deep it lies within the skin, what triggered it, and whether more than one condition is present simultaneously.
The first step is a detailed clinical examination of the skin. Your dermatologist assesses the pigmentation pattern, distribution, colour variation, border definition, and whether the pigmentation appears symmetrical or patchy.
This helps distinguish relatively straightforward sun-related pigmentation from more complex mixed conditions such as melasma, which often requires a different treatment approach.
Pigmentation is influenced by more than just ultraviolet exposure. Your dermatologist also reviews factors that may be triggering or maintaining pigmentation over time.
This may include your sun exposure habits, current skincare routine, previous cosmetic treatments, hormonal influences such as pregnancy or contraceptive use, medications, family history, and underlying inflammatory skin conditions.
In many patients, pigmentation treatment outcomes are limited when the underlying triggers remain unaddressed.
A dermatoscope is a handheld device that uses magnification and cross-polarised light to visualise structures beneath the skin surface.
Dermoscopic analysis can reveal fine pigment patterns, vascular changes, and clues about pigment depth that may not be visible to the naked eye alone. These findings support more accurate treatment selection, especially when deciding among topical, pigment laser, or vascular laser approaches.
A Wood’s lamp uses ultraviolet light to help estimate whether pigmentation sits primarily within the epidermis or deeper within the dermis.
This distinction matters because superficial epidermal pigmentation generally responds more readily to topical depigmenting agents and certain laser treatments. In contrast, deeper dermal pigmentation may require more gradual, specialist-led laser management.
Wood’s lamp assessment also helps guide expectations around treatment response and recurrence risk.
Most pigmentation conditions can be diagnosed clinically without invasive testing. However, a skin biopsy may occasionally be recommended if pigmentation has atypical features, changes unpredictably, or requires confirmation of a less common diagnosis.
This may include situations where a dermatologist needs to rule out suspicious pigmented lesions, dermal melanocytosis, or other uncommon pigmentary disorders.
Getting the diagnosis right is one of the strongest predictors of successful pigmentation treatment outcomes.
A dermatological approach to pigmentation treatment works in layers: sun protection forms the foundation, prescription topicals inhibit melanin at the source, oral medications stabilise overactive pigment cells from within, and lasers are calibrated tools layered on top to target what topicals alone cannot reach.
The right combination depends on your pigmentation type, skin tone, and individual response.
Every pigmentation treatment plan should start with sun protection. Without it, pigmentation often recurs, even after laser treatment.
Daily broad-spectrum sunscreen with SPF 50+ and PA+++ protection should be applied generously and reapplied every two to three hours when outdoors, especially in Singapore’s high-UV environment.
During active treatment phases, physical sunscreens containing zinc oxide or titanium dioxide are often preferred because they are generally less irritating and reflect ultraviolet radiation away from the skin.
Physical sun barriers also matter, particularly in the four to six weeks after laser treatment. Wide-brimmed hats, sunglasses, umbrellas, and avoiding prolonged sun exposure during peak UV hours, typically between 10am and 4pm, help reduce the risk of rebound pigmentation.
For melasma, ultraviolet light is not the only trigger. Visible light and heat exposure from cooking, hot showers, and saunas may also worsen pigmentation over time.
Prescription-strength topical treatments are often the second layer of pigmentation management. Different ingredients target pigmentation through different pathways, and the right combination depends on the type of pigmentation, skin sensitivity, and whether the condition is epidermal, dermal, or mixed.
Many of these pigmentation treatments are prescription-grade and are not interchangeable with over-the-counter products containing similar ingredients. Effectiveness depends on factors such as concentration, formulation, delivery vehicle, and dermatologist-guided usage.
In selected cases, particularly melasma or more persistent pigmentation conditions, a dermatologist may discuss oral medications as part of a broader treatment plan.
These are highly individualised treatment decisions made in consultation with your dermatologist following appropriate medical assessment.
DermAlly recommends the Pico laser as an effective treatment for superficial and deep pigmentation. Pico delivers ultra-short, high-intensity energy pulses, measured in picoseconds (trillionths of a second), directly to the targeted pigmentation.
This rapid pulsing technique effectively shatters pigment particles into microscopic fragments without generating significant heat, helping minimise damage to surrounding skin tissue. Once the pigment particles are broken down, the body’s natural lymphatic system gradually removes them, resulting in a visible lightening of the pigmented area over time.
The downtime for Pico laser treatment is minimal.
At DermAlly, our pico laser platform delivers multiple wavelengths: typically 532nm for superficial pigmentation and 1064nm for deeper pigmentation, with safer treatment for darker Fitzpatrick skin types.
Wavelength selection is calibrated to the patient’s specific pigmentation type and skin tone. Using the wrong wavelength on the wrong skin type can lead to poor outcomes or trigger PIH, which is one reason specialist supervision matters.
Beyond breaking down pigment particles, the pico laser also stimulates collagen production within the dermis. Many patients see secondary improvements in skin texture, resilience, and pore appearance as their pigmentation fades; though this is an adjunct benefit, not the primary treatment goal.
Q-switched Nd:YAG laser at 1064nm has an established history in dermatology and remains useful for selected pigmentation conditions. Its longer pulse duration generates more photothermal energy than picosecond lasers, which influences both where it is used and how cautiously it must be applied.
In clinical practice, the Q-switched laser is most commonly considered for deeper dermal pigmentation conditions such as Hori’s nevus and nevus of Ota, where its depth of penetration and treatment dynamics remain well studied. It may also be used in selected patients with other forms of pigmentation where the pico laser is not available or not clinically indicated.
For melasma, Q-switched protocols require careful low-fluence settings and close monitoring. The thermal component of Q-switched energy can worsen inflammation and trigger rebound pigmentation if settings are too aggressive, which is why the pico laser is increasingly preferred for melasma management in many clinical settings. Downtime is generally minimal, ranging from one to three days.
Q-switched lasers emit light in extremely short, high-intensity bursts, making them effective at reaching pigments in deeper skin layers without damaging surrounding tissue. The laser energy permeates the skin and breaks down pigment into tiny particles. The body’s natural healing processes then work to absorb and eliminate these fragments over time, gradually lightening the stubborn pigmentation.
The fractional laser is applied precisely to the affected areas, targeting pigmentation without harming the surrounding skin.
Stubborn pigmentation, particularly melasma, often involves more than excess melanin alone. In many patients, there is also an underlying vascular component, in which overactive blood vessels within the dermis help sustain inflammation and ongoing pigment activity even when surface pigmentation temporarily fades.
Yellow laser targets this vascular component directly. Its 577nm wavelength is selectively absorbed by haemoglobin within superficial blood vessels, helping reduce the vascular “feeding ground” that may contribute to persistent or recurrent pigmentation.
This is one reason combination treatment plans are commonly used in dermatologist-led pigmentation management. While the pico laser targets and fragments pigment particles, the yellow laser addresses the underlying vascular component. Treating both pathways together often yields more stable improvement than relying on a single treatment modality, particularly in recurrent melasma cases.
A yellow laser is also the appropriate treatment approach for PIE, which refers to the persistent red marks left behind after acne or skin inflammation heals. Unlike PIH, which involves excess melanin, PIE is vascular in nature and is therefore not effectively treated with pigment-focused lasers alone.
Your dermatologist may recommend combining laser treatments with other methods, such as microneedling and chemical peels, for complex or stubborn pigmentation.
Microneedling uses fine needles to create controlled micro-channels in the skin, stimulating collagen production and supporting the reduction of post-inflammatory pigmentation.
Explore DermAlly’s Fractional CO2 Laser and Fractional Microneedling Radiofrequency (RF) Treatment.
Chemical peels use acids such as glycolic, lactic, or salicylic acid to exfoliate the skin's surface, promoting cell turnover and fading dark spots. Peels range in intensity, with deeper peels requiring professional application and aftercare.
Laser is a useful tool for many pigmentation conditions, but it is not automatically the right starting point for every patient. In some situations, laser treatment may worsen inflammation, increase the risk of post-inflammatory hyperpigmentation, or delay proper diagnosis and treatment.
This is one reason dermatologist-led assessment matters before pigmentation laser treatment begins.
Laser may not be appropriate, or may need to be postponed, in the following situations:
Our dermatologists will recommend an alternative pathway when a laser is not the right starting point for your pigmentation removal treatment.
Pigmentation conditions can look similar on the surface while behaving very differently underneath the skin. When treatment is selected without accurately identifying the pigmentation type, depth, and underlying trigger, outcomes can become unpredictable.
Using the wrong laser wavelength for the wrong pigmentation type may trigger paradoxical darkening, in which the skin produces even more melanin and the pigmentation becomes darker than before treatment.
In darker Asian skin types, overly aggressive laser settings may also trigger post-inflammatory hyperpigmentation (PIH), creating new pigmentation while attempting to treat existing pigment.
Melasma is one of the clearest examples of why diagnosis matters. Aggressive treatment without proper pigment stabilisation and maintenance protocols can worsen inflammation and make melasma more persistent over time.
Pigmentation may also continue recurring when the underlying trigger remains active. For example, treating pigmentation without controlling ongoing acne, eczema, hormonal triggers, or ultraviolet exposure often leads to relapse once treatment stops.
Medical evaluation also matters because not every pigmented lesion is purely cosmetic. A suspicious or changing mole treated cosmetically without proper assessment could delay the diagnosis of skin cancer or another underlying skin condition.
These are the reasons our pigmentation removal plans start with a dermatologist consultation rather than a laser session.
Laser and topical treatments can significantly reduce existing pigmentation, but they do not remove the underlying tendency for pigment cells to reactivate. Without ongoing preventive care, recurrence is common, particularly in conditions such as melasma and post-inflammatory hyperpigmentation.
Sun protection is the single most important preventive measure. Broad-spectrum sunscreen with SPF 50+ and PA++++ protection should be applied every morning and reapplied every two to three hours during outdoor exposure. In Singapore’s year-round high-UV environment, consistent daily use is a medical requirement rather than a cosmetic preference.
For melasma in particular, visible light and heat are also recognised triggers alongside ultraviolet radiation. Physical sun barriers such as wide-brimmed hats, sunglasses, and umbrellas provide additional protection, particularly during the four to six weeks following any laser treatment.
Managing active inflammatory skin conditions is equally important. Ongoing acne, eczema, or contact dermatitis continues to trigger post-inflammatory hyperpigmentation even after laser treatment has improved existing marks. Controlling the source of inflammation prevents new pigmentation from forming while existing pigmentation fades.
Skincare habits also influence recurrence risk. Aggressive exfoliation, unsuitable active ingredients, and over-stripping the skin barrier can trigger inflammation and worsen pigmentation in susceptible skin. A gentle, non-irritating routine supports treatment outcomes and reduces the risk of self-induced pigmentary changes.
Avoiding picking at acne lesions, insect bites, or healing skin is important, as even minor trauma can trigger post-inflammatory hyperpigmentation in Asian skin types.
For patients on active treatment plans, topical depigmenting agents such as tranexamic acid, hydroquinone, or azelaic acid are often continued as maintenance between sessions to support pigment stability and reduce recurrence. Selected patients with melasma may also benefit from oral sun-protection supplements, such as Polypodium leucotomos extract, as an adjunctive measure.
Because melasma is a chronic condition, long-term management is structured rather than event-based. Maintenance sessions, ongoing sun protection, trigger control, and periodic dermatologist review are typically part of the care plan rather than a sign that initial treatment has failed.
Laser and pigmentation treatments vary in effectiveness based on factors such as pigmentation type, skin tone, and individual skin response. Setting realistic expectations is important, as results are typically gradual, and some pigmentation may not completely fade.
Many people mistakenly expect dramatic results after a single treatment session. However, while laser treatments can be highly effective, they take time to produce results… Visible improvements often take several weeks to months as the skin naturally heals and renews. Furthermore, some pigmentation issues may need multiple treatment sessions to achieve results and require periodic maintenance treatments to prevent recurrence.
For chronic conditions such as melasma, treatment is ongoing management, not a single fix. Maintenance regimens, ongoing sun protection, and periodic in-clinic sessions are typically part of the long-term plan.
At DermAlly, our dermatologists are direct about outcomes: while superficial sun spots and freckles can often be significantly improved, melasma is a chronic, relapsing condition. The goal of melasma treatment is long-term control and meaningful fading, not a permanent cure.
Owning this clinical reality upfront is how we set expectations that match what evidence-based treatment can actually deliver.
Consultation for pigmentation at DermAlly begins with a comprehensive clinical history covering how long the pigmentation has been present, where it appears, whether it is stable or changing, previous treatments and responses, sun exposure habits, current skincare products, and hormonal history, including pregnancy, contraceptive use, and perimenopause.
Physical examination includes assessment of pigmentation pattern, distribution, colour variation, border definition, and symmetry. Where indicated, further evaluation is performed using dermoscopy to assess pigment depth and vascular changes, and Wood’s lamp examination to help distinguish epidermal from dermal pigmentation.
Where clinically indicated, further assessment may include:
Following the assessment, a staged treatment plan is discussed with the patient. This covers the confirmed pigmentation type and depth, the recommended treatment approach and the reasoning behind it, expected timelines and realistic outcomes, maintenance requirements, and any relevant considerations such as pregnancy, photosensitising medications, or contraindications to specific laser wavelengths.
Patients are also advised on sun protection requirements before and after treatment, and what to do if pigmentation temporarily worsens during the early stages of certain treatment protocols.
Singapore’s Private Hospitals and Medical Clinics (PHMC) Act and Healthcare Services Act (HCSA) restrict the use of before-and-after photography in medical advertising. DermAlly fully adheres to these guidelines.
During consultation, our dermatologists discuss realistic expectations based on your specific pigmentation type, skin tone, and treatment plan. We support these guidelines as part of patient-centred ethical practice.
Hyperpigmentation is a broad term that refers to any area of skin becoming darker than the surrounding skin. This can happen after acne, eczema, skin irritation, inflammation, injury, or sun exposure, and the marks are often scattered or unevenly distributed.
Melasma is a specific type of pigmentation disorder. It typically presents as symmetrical brown or grey-brown patches across the cheeks, forehead, upper lip, or nose bridge, often appearing on both sides of the face in a mirrored pattern. Melasma is commonly linked to hormonal influences such as pregnancy, contraceptive use, or perimenopause, and is also triggered by ultraviolet exposure and heat.
Because different pigmentation conditions can overlap, a dermatologist confirms the diagnosis through clinical examination and tools such as dermoscopy and Wood’s lamp assessment.
Laser treatments can be effective for many types of pigmentation, but effectiveness depends significantly on the type and depth of pigmentation being treated, the wavelength selected, and how the skin responds. Pico laser is commonly used for superficial to mid-depth pigmentation with generally minimal downtime, while conditions such as melasma require a more cautious, lower-fluence approach.
While many treatments can significantly reduce pigmentation, complete removal may not always be possible. The effectiveness of treatment depends on the type of pigmentation and individual response.
Some side effects you may experience include temporary redness, swelling, or irritation. However, most of them are mild and resolve quickly. Discuss potential risks with your dermatologist before treatment.
Pigmentation treatment can be tailored to most skin types, including Asian and darker skin tones. However, darker Fitzpatrick IV–VI skin types carry a naturally higher risk of post-inflammatory hyperpigmentation (PIH), especially when aggressive laser settings or unsuitable wavelengths are used.
This is why treatment calibration matters. Dermatologists adjust factors such as wavelength, fluence, pulse duration, and treatment intensity based on your skin tone, skin pigmentation type, and risk of inflammation. In many Asian patients with skin, longer wavelengths such as 1064nm are often preferred over shorter wavelengths such as 532nm because they generally carry a lower risk of triggering rebound pigmentation.
Pre- and post-treatment protocols also play an important role. In some cases, topical treatment is used first to stabilise pigment activity before laser treatment begins.
The goal is not simply to “remove pigment” but to do so while minimising the risk of worsening pigmentation.
Preventative measures include wearing broad-spectrum sunscreen daily, avoiding excessive sun exposure, and using gentle skincare products. Regular dermatological check-ups can also help monitor skin changes.
Most home remedies have limited and inconsistent evidence for treating pigmentation. Over-the-counter brightening products may offer mild improvement in very superficial marks, but they are generally insufficient for established pigmentation conditions such as melasma, PIH, or dermal pigmentation. A dermatologist’s assessment helps determine which treatments are actually appropriate for the type and depth of pigmentation present.
Many patients notice improvements within a few weeks, while full results may take several months, especially with laser treatments.
Most pigmentation removal treatments are well-tolerated, but some procedures may cause mild discomfort. Topical anaesthetics can minimise pain during treatment.
After pigmentation treatment, avoiding direct sun exposure, tanning beds, and harsh skincare products is crucial. Following your dermatologist’s aftercare instructions will help ensure optimal healing and results.
Pigmentation recurrence is common, particularly in conditions such as melasma and in patients prone to post-inflammatory hyperpigmentation (PIH). Laser treatment can reduce visible pigment, but it does not remove the underlying tendency for pigment cells to reactivate.
Common triggers include ongoing ultraviolet exposure, inconsistent sunscreen use, hormonal influences such as pregnancy or contraceptive use, heat exposure, and untreated inflammation from acne or eczema. Melasma in particular is considered a chronic and recurrent condition. Long-term management often involves maintenance treatment, trigger control, and lifelong sun protection.
No. Melasma behaves very differently from isolated sun spots. Sun spots are usually superficial and caused primarily by cumulative ultraviolet exposure, while melasma is a mixed pigmentation condition influenced by hormones, heat, vascular changes, genetics, and ultraviolet light.
Aggressive lasers commonly used for sun spots may worsen melasma and trigger rebound pigmentation if used incorrectly. Melasma treatment often involves lower-fluence laser settings combined with topical depigmenting agents, strict sun protection, and, in selected cases, oral medication such as tranexamic acid. A dermatologist confirms the diagnosis before recommending treatment.
Most pigmentation laser treatments are generally postponed during pregnancy as a precaution. Many topical depigmenting agents commonly used in pigmentation management, including hydroquinone and retinoids, are also not typically recommended during pregnancy.
Pregnancy-related pigmentation, sometimes called chloasma or “pregnancy melasma”, may improve naturally after delivery, although some patients continue to experience persistent pigmentation afterwards.
If you are pregnant, breastfeeding, or planning a pregnancy, it is important to inform your dermatologist during your consultation so that pigmentation treatment options can be assessed safely and appropriately for your situation.
#05-01/02
#03-08
Book an appointment with our expert dermatologists. Please select your preferred clinic below.
